Anti-galactocerebroside (GalC) antibodies have been reported to inhibi
t myelin formation, cause demyelination, and block HIV-I infection of
neural cells. We examined the binding of 3 monoclonal and polyclonal a
nti-GalC antibodies to a panel of purified glycolipids by ELISA and by
an immunospot assay on nitrocellulose blots. All 3 antibodies bound s
trongly to GM1 ganglioside, monogalactosyl diglyceride, and asialo-GM1
, and 2 of the antibodies bound to GD1b and psychosine. The anti-GalC
antibodies also bound to 3 glycoprotein bands in human neuroblastoma c
ells on Western blot, and binding to the proteins was abolished by pre
-treatment with pronase or with periodate which oxidizes the terminal
carbohydrate residues. These results indicate that anti-GalC antibodie
s cross react with oligosaccharide determinants of other glycolipids a
nd glycoproteins, and that these cross-reactivities may be responsible
for some of the biological effects of the anti-GalC antibodies.